Abstract

BACKGROUNDThe effect of hepatitis delta virus (HDV) infection on the clinical course of cirrhosis type B is poorly defined.AIMSTo investigate the impact of HDV status on morbidity and mortality in...

Highlights

  • The eVect of hepatitis delta virus (HDV) infection on the clinical course of cirrhosis type B is poorly defined

  • ANTI-HDV/HBeAG STATUS We evaluated 200 white patients with hepatitis B surface antigen (HBsAg) positive compensated cirrhosis who fulfilled the inclusion criteria

  • Our results indicate that HDV infection modifies to a certain extent the clinical and serological presentation of HBsAg positive cirrhosis

Read more

Summary

Dipartimento di Medicina Clinica e

Sperimentale, Clinica Medica 2a, University of Padova, Italy G Giustina min concentration, -globulin concentration, and HDV status as significant independent prognostic variables. Bispebjerg University Hospital, Copenhagen, Denmark E Christensen tion, and mortality was increased by a factor of 3.2 (1.0 to 10), 2.2 (0.8 to 5.7), and 2.0 (0.7 to 5.7) respectively in anti-HDV positive relative to HDV negative cirrhotic. University of risk for HCC was 13, 4, and 2% for Sassari, Italy G Realdi anti-HDV positive/HBeAg negative, antiHDV negative/HBeAg negative, and anti-. Conclusions—HDV infection increases the risk for HCC threefold and for Correspondence to: Dr G Fattovich, Servizio mortality twofold in patients with cirrhosis type B. There are insuYcient data to clarify whether HDV alters the clinical course of HBV related compensated cirrhosis and increases the risk of hepatocellular carcinoma (HCC). Namely incidence of complications of cirrhosis and incidence of HCC, and mortality were compared in anti-HDV positive and negative patients

Materials and methods
SEROLOGICAL TESTING
STATISTICAL ANALYSIS
BASELINE CHARACTERISTICS ACCORDING TO
CLINICAL OUTCOME ACCORDING TO
Patients at risk
Age Albumin
Variable regression coeYcient SE p Value
Univariate analysis Multivariate analysis
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.